论文部分内容阅读
对１５例经肝动脉碘化油栓塞（ＬＰＤ）治疗后施行二期切除的原发性肝癌患者肝脏中的坏死、残癌和癌周正常肝组织三个不同部位碘含量进行测定。结果：坏死组织中的碘含量最高，平均为５６３．６４ｎｇ／ｇ，经方差分析均高于癌周正常肝组织及残新产癌组织，呈显著性差异（Ｐ＜０．０１或Ｐ＜０．０５１）。提示碘在肝脏中的分布与临床效果之间存在密切关系，可通过肝脏中不同部位碘含量的测定，以含量为指标来评估ＬＰＤ疗法的效果。
The iodine content in the liver of necrosis, residual cancer, and normal tissue of the liver tissue at the periphery of the cancer was measured in 15 patients with primary hepatocellular carcinoma treated with hepatic arterial iodized oil embolism (LPD). Results: The highest content of iodine in necrotic tissues was 563.64 ng/g. The analysis of variance was higher than that of normal liver tissue and residual neocarcinoma tissues. There was a significant difference (P<0.01 or P<0). .051). It suggests that there is a close relationship between the distribution of iodine in the liver and clinical efficacy. The effect of LPD therapy can be assessed by measuring the iodine content in different parts of the liver and using the content as an indicator.